SCM Lifescience Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 18, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	38,899	38,704	77,366	175,143	233,826	586,015
Market Cap Growth	26.45%	-49.97%	-55.83%	-25.10%	-60.10%	-
Enterprise Value	30,001	40,480	65,415	170,464	217,178	551,155
Last Close Price	880.00	1891.00	3780.00	10694.08	14394.46	36522.70
PS Ratio	25.21	46.93	111.21	442.30	532.32	1831.26
PB Ratio	1.60	2.73	3.78	7.15	5.24	9.29
P/TBV Ratio	1.63	2.87	3.82	7.24	5.28	9.34
EV/Sales Ratio	19.44	49.08	94.03	430.49	494.42	1722.33
Debt / Equity Ratio	0.11	0.49	0.19	0.24	0.14	0.11
Net Debt / Equity Ratio	-0.36	0.43	-0.42	-0.13	-0.30	-0.45
Net Debt / EBITDA Ratio	1.21	-0.58	0.70	0.28	1.22	1.93
Net Debt / FCF Ratio	0.54	-0.43	0.69	0.27	0.96	2.32
Asset Turnover	0.06	0.03	0.02	0.01	0.01	0.01
Inventory Turnover	2.38	1.10	1.53	1.29	0.85	0.55
Quick Ratio	6.34	0.18	10.85	1.97	2.27	10.85
Current Ratio	6.61	0.35	11.55	2.20	2.33	11.07
Return on Equity (ROE)	-41.87%	-71.44%	-106.53%	-66.34%	-41.82%	-23.08%
Return on Assets (ROA)	-21.08%	-29.10%	-27.81%	-18.06%	-11.66%	-17.14%
Return on Capital Employed (ROCE)	-31.10%	-64.90%	-53.60%	-44.20%	-26.80%	-22.00%
Earnings Yield	-21.18%	-31.98%	-30.97%	-13.09%	-9.63%	-1.64%
FCF Yield	-42.55%	-36.50%	-15.99%	-6.67%	-6.02%	-2.11%
Buyback Yield / Dilution	-10.66%	-25.01%	-12.85%	-21.21%	-12.79%	-101.51%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.